News
Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last month, is set to return to ...
15h
TipRanks on MSNNovavax Stock Surges Amid Strategic GainsNovavax ( ($NVAX) ) has risen by 24.00%. Read on to learn why. Novavax has experienced a notable 24.00% increase in its stock price over the past ...
The Food and Drug Administration restored a top vaccine regulator to his position at the agency just weeks after firing him.
At the U.S. Food and Drug Administration's (FDA) request, Vinay Prasad is returning to the role of director of the Center for ...
Latest move to cut funding for vaccines is not down to US health secretary. It is part of Trump’s wider war on science.
Less than weeks after stepping down, Prasad will return to lead CBER “at the FDA’s request,” according to an HHS spokesperson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results